For each location and color axis,
Figure 2 shows the adaptation magnitude measured as physical contrast at the identity point (Nulled-Contrast) for each color axis, averaged over the group of patients, and paired with the average for the group of age-similar controls. A smaller Nulled-Contrast represents weaker and slower adaptation. The differences in each comparison were small, but in 15 of 15 comparisons, adaptation was weaker and slower for the glaucoma group. If there were no actual difference in adaptation between the groups, the chance of this happening would be 1/32,768 (calculated from the binomial cumulative distribution function with
P = 0.5), providing strong evidence against the assumption of no difference. In addition, the results showed that controls adapt slower for central stimuli than for peripheral presentations. This is the classic Troxler effect and has been shown to be due to the effects of fixational eye-movements causing transient responses in ganglion cells.
24 An interesting aspect of the results is that the foveal slowing does not happen for glaucoma patients, so that the difference between the groups is reduced. The cause remains to be investigated systematically, but since detection thresholds for all 3 color axes have been shown to be elevated in the fovea of glaucoma patients,
15 it is possible that compromised macular ganglion cells do not generate the normal transients from miniature eye movements that are required to improve sensitivity to low temporal frequencies.
27 The peripheral results, being less affected by eye movements, may thus provide better comparisons of neuronal adaptation. To support our inferences, we also ran an ANOVA on the Nulled-Contrasts (
Table 3). The marginal effect of Group (Patients versus Controls) was highly significant (
P < 2e-16). There was a small significant effect of color axis, due to adaptation being weaker for the L-D axis than the other two, consistent with previous results.
6 The effects of retinal location and all interactions were nonsignificant.